These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 686171)

  • 1. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.
    DeLean A; Munson PJ; Rodbard D
    Am J Physiol; 1978 Aug; 235(2):E97-102. PubMed ID: 686171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model-free approach to estimation of relative potency in dose-response curve analysis.
    Guardabasso V; Rodbard D; Munson PJ
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E357-64. PubMed ID: 3826362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and comparison of sigmoidal curves: application to dose-response data.
    Meddings JB; Scott RB; Fick GH
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G982-9. PubMed ID: 2610264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel line and relative potency analysis of bioassay and radioimmunoassay data using a desk top computer.
    Pekary AE
    Comput Biol Med; 1979; 9(4):355-62. PubMed ID: 535360
    [No Abstract]   [Full Text] [Related]  

  • 5. A powerful, yet easy to use, computerized analysis of competitive protein binding and radioimmunoassay data.
    English JE
    Comput Programs Biomed; 1981; 13(3-4):225-37. PubMed ID: 7318422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay data processing with a small programmable calculator.
    Davis SE; Munson PJ; Jaffe ML; Rodbard D
    J Immunoassay; 1980; 1(1):15-25. PubMed ID: 7229042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 'rogue' points on non-linear fitting.
    Barlow RB
    Trends Pharmacol Sci; 1993 Nov; 14(11):399-403. PubMed ID: 8296398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments of computer-based estimation of pA2 values and associated analysis.
    Stone M; Angus JA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):705-18. PubMed ID: 731426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioassay of circulating luteinizing hormone in the rhesus monkey: comparison with radioimmunoassay during physiological changes.
    Dufau ML; Hodgen GD; Goodman AL; Catt KJ
    Endocrinology; 1977 Jun; 100(6):1557-65. PubMed ID: 404130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A method for describing monotonic dose-effect curves and areas in yes/no reactions (author's transl)].
    Safer A
    Arzneimittelforschung; 1978; 28(9):1512-5. PubMed ID: 582546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response characteristics of uterine responses in rats exposed to estrogen agonists.
    Barton HA; Andersen ME; Allen BC
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):133-49. PubMed ID: 9927563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized radioimmunoassay curve fitting program suitable for use on desktop calculators.
    Van der Sluijs Veer G; Kennedy JC
    Clin Chim Acta; 1978 Aug; 88(1):27-30. PubMed ID: 679491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A versatile method for simultaneous analysis of families of curves.
    Guardabasso V; Munson PJ; Rodbard D
    FASEB J; 1988 Mar; 2(3):209-15. PubMed ID: 3350235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Model and inference for quantal response pharmacological assay].
    Kawai N; Goto M
    Nihon Yakurigaku Zasshi; 2000 Jul; 116(1):29-35. PubMed ID: 10976450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response curve analysis of gastric secretory responses in the dog and man to impromidine: a new histamine-H2-receptor agonist.
    McIsaac RL; Johnston BJ; Flannery MC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):186-90. PubMed ID: 6131998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new bioassay for the immunocytokine L19-IL2 for simultaneous analysis of both functional moieties.
    Winter J; Barbin K; Bacci C; Bunte T
    J Pharm Biomed Anal; 2011 Jan; 54(1):81-6. PubMed ID: 20828971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal statistical design of radioimmunoassays and competitive protein-binding assays.
    Chang PC; Rubin RT; Yu M
    Endocrinology; 1975 Apr; 96(4):973-81. PubMed ID: 1120486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay and bioassay data processing using a logistic curve fitting routine adapted to a desk top computer.
    Grotjan HE; Steinberger E
    Comput Biol Med; 1977 Apr; 7(2):159-63. PubMed ID: 852277
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.
    Burstein S; Schaff-Blass E; Blass J; Rosenfield RL
    J Clin Endocrinol Metab; 1985 Sep; 61(3):508-13. PubMed ID: 3894406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHARMFIT--a nonlinear fitting program for pharmacology.
    Mattes A; Witte K; Hohmann W; Lemmer B
    Chronobiol Int; 1991; 8(6):460-76. PubMed ID: 1799928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.